Clinical pharmacology

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


155 publications

In press | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
Optimisation of vancomycin exposure in neonates based on the best level of evidence.
Dao K., Guidi M., André P., Giannoni E., Basterrechea S., Zhao W., Fuchs A., Pfister M., Buclin T., Csajka C. Pharmacological research p. 104278. Peer-reviewed.
 
Contribution of genetic background and clinical D:A:D risk score to chronic kidney disease in Swiss HIV-positive persons with normal baseline estimated glomerular filtration rate.
Dietrich L.G., Barceló C., Thorball C.W., Ryom L., Burkhalter F., Hasse B., Furrer H., Weisser M., Steffen A., Bernasconi E. et al. Clinical infectious diseases. Peer-reviewed.
 
Amisulpride: Real-World Evidence of Dose Adaptation and Effect on Prolactin Concentrations and Body Weight Gain by Pharmacokinetic/Pharmacodynamic Analyses.
Glatard A., Guidi M., Delacrétaz A., Dubath C., Grosu C., Laaboub N., von Gunten A., Conus P., Csajka C., Eap C.B. Clinical pharmacokinetics. Peer-reviewed.
 
Compassionate Use of Letermovir in a 2-Year-Old Immunocompromised Child With Resistant Cytomegalovirus Disease.
Pérez Marín M., Decosterd L.A., Andre P., Buclin T., Mercier T., Murray K., Rizzi M., Meylan P., Jaton-Ogay P., Opota O. et al. Journal of the Pediatric Infectious Diseases Society. Peer-reviewed.
 
Therapeutic drug monitoring of targeted anticancer protein kinase inhibitors in routine clinical use: A critical review.
Cardoso E., Guidi M., Blanchet B., Schneider M.P., Decosterd L.A., Buclin T., Csajka C., Widmer N., 2020/02. Therapeutic drug monitoring, 42 (1) pp. 33-44. Peer-reviewed.
 
Pharmacokinetic profiles of boosted darunavir, dolutegravir and lamivudine in aging people living with HIV.
Courlet P., Stader F., Guidi M., Alves Saldanha S., Stoeckle M., Cavassini M., Battegay M., Buclin T., Decosterd L.A., Marzolini C. et al., 2020/01/01. AIDS, 34 (1) pp. 103-108. Peer-reviewed.
 
Gender medicine and oncology: report and consensus of an ESMO workshop.
Wagner A.D., Oertelt-Prigione S., Adjei A., Buclin T., Cristina V., Csajka C., Coukos G., Dafni U., Dotto G.P., Ducreux M. et al., 2019/12/01. Annals of oncology, 30 (12) pp. 1914-1924. Peer-reviewed.
 
Polypharmacy, Drug-Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV.
Courlet P., Livio F., Guidi M., Cavassini M., Battegay M., Stoeckle M., Buclin T., Alves Saldanha S., Csajka C., Marzolini C. et al., 2019/12. Open forum infectious diseases, 6 (12) pp. ofz531. Peer-reviewed.
 
Noninferiority of Simplified Dolutegravir Monotherapy Compared to Continued Combination Antiretroviral Therapy That Was Initiated During Primary Human Immunodeficiency Virus Infection: A Randomized, Controlled, Multisite, Open-label, Noninferiority Trial.
Braun D.L., Turk T., Tschumi F., Grube C., Hampel B., Depmeier C., Schreiber P.W., Brugger S.D., Greiner M., Steffens D. et al., 2019/10/15. Clinical infectious diseases, 69 (9) pp. 1489-1497. Peer-reviewed.
 
Gestion du traitement de l’asthme chez une femme enceinte
Levray Andréa, Berger Jérôme, Guignard Bertrand, Beney Johnny, Csajka Chantal, Panchaud Alice, 2019/10. pharmaJournal.
 
Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence - an update.
Fischer Fumeaux C.J., Morisod Harari M., Weisskopf E., Eap C.B., Epiney M., Vial Y., Csajka C., Bickle Graz M., Panchaud A., 2019/10. Expert opinion on drug safety, 18 (10) pp. 949-963. Peer-reviewed.
 
Therapiemanagement von Asthma bei einer schwangeren Frau
Levray Andréa, Berger Jérôme, Guignard Bertrand, Beney Johnny, Csajka Chantal, Panchaud Alice, 2019/10. pharmaJournal.
 
Escitalopram population pharmacokinetics in people living with human immunodeficiency virus and in the psychiatric population: Drug-drug interactions and probability of target attainment.
Courlet P., Guidi M., Glatard A., Alves Saldanha S., Cavassini M., Buclin T., Marzolini C., Eap C.B., Decosterd L.A., Csajka C. et al., 2019/09. British journal of clinical pharmacology, 85 (9) pp. 2022-2032. Peer-reviewed.
 
Population pharmacokinetics of dolutegravir: influence of drug-drug interactions in a real-life setting.
Barcelo C., Aouri M., Courlet P., Guidi M., Braun D.L., Günthard H.F., Piso R.J., Cavassini M., Buclin T., Decosterd L.A. et al., 2019/09/01. The Journal of antimicrobial chemotherapy, 74 (9) pp. 2690-2697. Peer-reviewed.
 
UHPLC-MS/MS assay for simultaneous determination of amlodipine, metoprolol, pravastatin, rosuvastatin, atorvastatin with its active metabolites in human plasma, for population-scale drug-drug interactions studies in people living with HIV.
Courlet P., Spaggiari D., Desfontaine V., Cavassini M., Alves Saldanha S., Buclin T., Marzolini C., Csajka C., Decosterd L.A., 2019/09/01. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1125 p. 121733. Peer-reviewed.
 
Emtricitabine and lamivudine concentrations in saliva: a simple suitable test for treatment adherence.
Courlet P., Decosterd L.A., Brown J.A., Alves Saldanha S., Marzolini C., Cavassini M., Stoeckle M., Csajka C., Labhardt N.D., Calmy A. et al., 2019/08/01. The Journal of antimicrobial chemotherapy, 74 (8) pp. 2468-2470. Peer-reviewed.
 
High concentration of plasma methoxytyramine: dopamine-producing tumour or Parkinson's disease therapy?
Chtioui H., Sadowski S.M., Winzeler B., Tschopp O., Grouzmann E., Abid K., 2019/07. Annals of clinical biochemistry, 56 (4) pp. 466-471. Peer-reviewed.
 
Influence of body weight and UGT2B7 polymorphism on varenicline exposure in a cohort of smokers from the general population.
Glatard A., Guidi M., Dobrinas M., Cornuz J., Csajka C., Eap C.B., 2019/07. European journal of clinical pharmacology, 75 (7) pp. 939-949. Peer-reviewed.
 
Prescribing issues in elderly individuals living with HIV.
Marzolini C., Livio F., 2019/07. Expert review of clinical pharmacology, 12 (7) pp. 643-659. Peer-reviewed.
 
Severe rosuvastatin accumulation with rhabdomyolysis due to drug interactions and low cardiac output syndrome.
Previsdomini M., Graziano E., Decosterd L., Courlet P., Perren A., Ceschi A., 2019/07. British journal of clinical pharmacology, 85 (7) pp. 1616-1618. Peer-reviewed.
 
Isavuconazole brain penetration in cerebral aspergillosis.
Lamoth F., Mercier T., André P., Pagani J.L., Pantet O., Maduri R., Guery B., Decosterd L.A., 2019/06/01. The Journal of antimicrobial chemotherapy, 74 (6) pp. 1751-1753. Peer-reviewed.
 
Défis dans la prise en charge du diabète en hémodialyse chronique [Challenges in managing diabetes in chronic hemodialysis]
Lamine F., Chtioui H., Schwotzer N., Pruijm M., Nobre D., Phan O., Ammor N., Andrey M., Grangier-Bernard P., Zanchi A., 2019/05/29. Revue medicale suisse, 15 (653) pp. 1132-1139. Peer-reviewed.
 
Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report.
Fraga M., Gouttenoire J., Sahli R., Chtioui H., Marcu C., Pascual M., Moradpour D., Vionnet J., 2019/05/24. BMC gastroenterology, 19 (1) p. 76. Peer-reviewed.
 
Clindamycin clearance during Cytosorb<sup>®</sup> hemoadsorption: A case report and pharmacokinetic study.
Poli E.C., Simoni C., André P., Buclin T., Longchamp D., Perez M.H., Ferry T., Schneider A.G., 2019/05. The International journal of artificial organs, 42 (5) pp. 258-262. Peer-reviewed.
 
Infections aiguës des voies respiratoires et urinaires au cabinet médical : quelques traitements en médecine complémentaire [Acute respiratory and urinary tract infections in medical practice : a selection of complementary medicines]
Dumitrascu A., Senn L., Rothuizen L.E., Rodondi P.Y., 2019/04/24. Revue medicale suisse, 15 (648) pp. 875-881. Peer-reviewed.
Population pharmacokinetics and pharmacodynamics of the artesunate-mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children.
Guidi M., Mercier T., Aouri M., Decosterd L.A., Csajka C., Ogutu B., Carn G., Kiechel J.R., 2019/04/18. Malaria journal, 18 (1) p. 139. Peer-reviewed.
Pharmacovigilance, hémovigilance, vaccinovigilance, tératovigilance… : quelles retombées imprévues pour les patients, les intervenants de santé et les systèmes de soins ?
Buclin Thierry, Foley Rose-Anna, Livio Françoise, 2019/04/11. Anthropologie & Santé.
Cardiac Implantable Electronic Device-Related Infection Due to Granulicatella adiacens.
Sendi P., Wustmann K., Büchi A.E., Noti F., Klaeser B., Sonderegger B., Auf der Maur C., Mercier T., Schwerzmann M., Ruppen C., 2019/04. Open forum infectious diseases, 6 (4) pp. ofz130. Peer-reviewed.
 
Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre.
Jermini M., Dubois J., Rodondi P.Y., Zaman K., Buclin T., Csajka C., Orcurto A., E Rothuizen L., 2019/03/25. Scientific reports, 9 (1) p. 5078. Peer-reviewed.
 
Sub-picomolar quantification of PTH 1-34 in plasma by UHPLC-MS/MS after subcutaneous injection of teriparatide and identification of PTH 1-33, its degradation product.
Eugster P.J., Chtioui H., Herren A., Dunand M., Cappelle D., Bourquin J., Buclin T., Grouzmann E., 2019/03/20. Journal of pharmaceutical and biomedical analysis, 166 pp. 205-212. Peer-reviewed.
 
Reply to L. Pala et al.
Wagner A.D., Özdemir B., Csajka C., 2019/02/10. Journal of clinical oncology, 37 (5) pp. 439-440. Peer-reviewed.
 
Multicenter Population Pharmacokinetic Study of Colistimethate Sodium and Colistin Dosed as in Normal Renal Function in Patients on Continuous Renal Replacement Therapy.
Leuppi-Taegtmeyer A.B., Decosterd L., Osthoff M., Mueller N.J., Buclin T., Corti N., 2019/02. Antimicrobial agents and chemotherapy, 63 (2). Peer-reviewed.
 
What is the cost of endoscopic submucosal dissection (ESD)? A medico-economic study.
Dahan M., Pauliat E., Liva-Yonnet S., Brischoux S., Legros R., Tailleur A., Carrier P., Charissoux A., Valgueblasse V., Loustaud-Ratti V. et al., 2019/02. United European gastroenterology journal, 7 (1) pp. 138-145. Peer-reviewed.
 
Pharmacovigilance [Pharmacovigilance update]
Abo Loha C., Livio F., 2019/01/09. Revue medicale suisse, 15 (N° 632-633) pp. 92-95. Peer-reviewed.
Adherence to intermittent preventive treatment for malaria in Papua New Guinean infants: A pharmacological study alongside the randomized controlled trial.
Sottas O., Guidi M., Thieffry B., Schneider M., Décosterd L., Mueller I., Genton B., Csajka C., Senn N., 2019. PloS one, 14 (2) pp. e0210789. Peer-reviewed.
 
Development and validation of a multiplex UHPLC-MS/MS method for the determination of the investigational antibiotic against multi-resistant tuberculosis macozinone (PBTZ169) and five active metabolites in human plasma.
Spaggiari D., Desfontaine V., Cruchon S., Guinchard S., Vocat A., Blattes E., Pitteloud J., Ciullini L., Bardinet C., Ivanyuk A. et al., 2019. PloS one, 14 (5) pp. e0217139. Peer-reviewed.
 
Imatinib Uptake into Cells is Not Mediated by Organic Cation Transporters OCT1, OCT2, or OCT3, But is Influenced by Extracellular pH.
Mettral J.B., Faller N., Cruchon S., Sottas L., Buclin T., Schild L., Choong E., Nahimana A., Decosterd L.A., 2019. Drug metabolism letters, 13 (2) pp. 102-110. Peer-reviewed.
Intravenous brivaracetam in status epilepticus: Correlation between loading dose, plasma levels and clinical response.
Aicua-Rapun I., André P., Rossetti A.O., Decosterd L.A., Buclin T., Novy J., 2019/01. Epilepsy research, 149 pp. 88-91. Peer-reviewed.
 
Leptomeningeal tumor response to combined MAPK/ERK inhibition in V600E-mutated gliomas despite undetectable CSF drug levels.
Hottinger A.F., Bensaid D., De Micheli R., Moura B., Mokhtari K., Cardoso E., Idbaih A., Stupp R., 2019/01/01. Annals of oncology, 30 (1) pp. 155-156. Peer-reviewed.
 
Prescribing issues in older adults living with HIV: thinking beyond drug-drug interactions with antiretroviral drugs.
Livio F., Marzolini C., 2019. Therapeutic advances in drug safety, 10 p. 2042098619880122. Peer-reviewed.
 
Therapeutic drug monitoring (TDM)
Pascal A., Widmer N., Buclin T., 2019. pp. 1-9 dans Swiss recommendations for adult cystic fibrosis care chap. 4.2.3, RMS Editions/Médecine et Hygiène.
 
Effect of renal clearance and continuous renal replacement therapy on appropriateness of recommended meropenem dosing regimens in critically ill patients with susceptible life-threatening infections.
Burger R., Guidi M., Calpini V., Lamoth F., Decosterd L., Robatel C., Buclin T., Csajka C., Marchetti O., 2018/12/01. The Journal of antimicrobial chemotherapy, 73 (12) pp. 3413-3422. Peer-reviewed.
Levetiracetam circulating concentrations and response in status epilepticus.
Perrenoud M., André P., Buclin T., Decosterd L.A., Rossetti A.O., Novy J., 2018/11. Epilepsy & behavior, 88 pp. 61-65. Peer-reviewed.
 
Maternal-fetal transmission and adverse perinatal outcomes in pregnant women infected with Zika virus: prospective cohort study in French Guiana.
Pomar L., Vouga M., Lambert V., Pomar C., Hcini N., Jolivet A., Benoist G., Rousset D., Matheus S., Malinger G. et al., 2018/10/31. BMJ, 363 pp. k4431. Peer-reviewed.
 
High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure.
Tyagi R.K., Gleeson P.J., Arnold L., Tahar R., Prieur E., Decosterd L., Pérignon J.L., Olliaro P., Druilhe P., 2018/10/01. BMC medicine, 16 (1) p. 181. Peer-reviewed.
 
Myoglobinuria in two patients with Duchenne muscular dystrophy after treatment with zoledronate: a case-report and call for caution.
Ivanyuk A., García Segarra N., Buclin T., Klein A., Jacquier D., Newman C.J., Bloetzer C., 2018/10. Neuromuscular disorders, 28 (10) pp. 865-867. Peer-reviewed.
 
Comparison against current standards of a DNA aptamer for the label-free quantification of tobramycin in human sera employed for therapeutic drug monitoring.
Tenaglia E., Ferretti A., Decosterd L.A., Werner D., Mercier T., Widmer N., Buclin T., Guiducci C., 2018/09/10. Journal of pharmaceutical and biomedical analysis, 159 pp. 341-347. Peer-reviewed.
 
DPP (Dipeptidyl Peptidase)-4 Inhibition Potentiates the Vasoconstrictor Response to NPY (Neuropeptide Y) in Humans During Renin-Angiotensin-Aldosterone System Inhibition.
Hubers S.A., Wilson J.R., Yu C., Nian H., Grouzmann E., Eugster P., Shibao C.A., Billings F.T., Jafarian Kerman S., Brown N.J., 2018/09. Hypertension, 72 (3) pp. 712-719. Peer-reviewed.
Efficacy and safety of continuous infusions with elastomeric pumps for outpatient parenteral antimicrobial therapy (OPAT): an observational study.
Voumard R., Gardiol C., André P., Arensdorff L., Cochet C., Boillat-Blanco N., Decosterd L., Buclin T., de Vallière S., 2018/09/01. The Journal of antimicrobial chemotherapy, 73 (9) pp. 2540-2545. Peer-reviewed.
 
Ethical approval for multicenter cohort studies on drug exposure during pregnancy: A survey among members of the European Network of Teratology Information Services (ENTIS).
Winterfeld U., Weber-Schöndorfer C., Schaefer C., von Elm E., Buclin T., 2018/09. Reproductive toxicology, 80 pp. 68-72. Peer-reviewed.
 
Population Pharmacokinetic Study of Amoxicillin-Treated Burn Patients Hospitalized at a Swiss Tertiary-Care Center.
Fournier A., Goutelle S., Que Y.A., Eggimann P., Pantet O., Sadeghipour F., Voirol P., Csajka C., 2018/09. Antimicrobial agents and chemotherapy, 62 (9) pp. e00505-18. Peer-reviewed.
 
Sensitive quantification of the somatostatin analog AP102 in plasma by ultra-high pressure liquid chromatography-tandem mass spectrometry and application to a pharmacokinetic study in rats.
Eugster P.J., Boyle C.N., Prod'hom S., Tarasco E., Buclin T., Lutz T.A., Harris A.G., Grouzmann E., 2018/09. Drug testing and analysis, 10 (9) pp. 1448-1457. Peer-reviewed.
 
Quantification of vanillylmandelic acid, homovanillic acid and 5-hydroxyindoleacetic acid in urine using a dilute-and-shoot and ultra-high pressure liquid chromatography tandem mass spectrometry method.
Grouzmann E., Centeno C., Eugster P.J., 2018/08/28. Clinical chemistry and laboratory medicine, 56 (9) pp. 1533-1541. Peer-reviewed.
 
Boosted darunavir, emtricitabine and tenofovir pharmacokinetics in sthe early and late postgastric bypass surgery periods.
Baettig V., Courlet P., Delko T., Battegay M., Marzolini C., 2018/08/24. AIDS, 32 (13) pp. 1903-1905. Peer-reviewed.
 
Antiepileptika in der Stillzeit : Wie beraten wir die Mütter? [Use of antiepileptic drugs during breastfeeding : What do we tell the mother?]
Crettenand M., Rossetti A.O., Buclin T., Winterfeld U., 2018/08. Der Nervenarzt, 89 (8) pp. 913-921. Peer-reviewed.
 
Association of Patient Sex With Chemotherapy-Related Toxic Effects: A Retrospective Analysis of the PETACC-3 Trial Conducted by the EORTC Gastrointestinal Group.
Cristina V., Mahachie J., Mauer M., Buclin T., Van Cutsem E., Roth A., Wagner A.D., 2018/07/01. JAMA oncology, 4 (7) pp. 1003-1006. Peer-reviewed.
Stable HIV-1 reservoirs on dolutegravir maintenance monotherapy: the MONODO study.
Sculier D., Doco-Lecompte T., Yerly S., Metzner K.J., Decosterd L.A., Calmy A., 2018/06/22. HIV medicine, 19 (8) pp. 572-577. Peer-reviewed.
 
Fractures vertébrales multiples à l’arrêt du denosumab: comment les éviter? [Multiple Vertebral Fractures after Denosumab Discontinuation: How to Avoid Them?]
Lamy O., Gonzalez Rodriguez E., Stoll D., Aubry-Rozier B., Livio F., 2018/06. Praxis, 107 (12) pp. 649-654. Peer-reviewed.
 
The Antimalarial Drug Artesunate Attenuates Cardiac Injury in A Rodent Model of Myocardial Infarction.
Khan A.I., Kapoor A., Chen J., Martin L., Rogazzo M., Mercier T., Decosterd L., Collino M., Thiemermann C., 2018/06. Shock, 49 (6) pp. 675-681. Peer-reviewed.
 
Zika virus, vaccines, and antiviral strategies.
Masmejan S., Baud D., Musso D., Panchaud A., 2018/06. Expert review of anti-infective therapy, 16 (6) pp. 471-483. Peer-reviewed.
 
LC-MS/MS method for the simultaneous analysis of seven antimalarials and two active metabolites in dried blood spots for applications in field trials: Analytical and clinical validation.
Gallay J., Prod'hom S., Mercier T., Bardinet C., Spaggiari D., Pothin E., Buclin T., Genton B., Decosterd L.A., 2018/05/30. Journal of pharmaceutical and biomedical analysis, 154 pp. 263-277. Peer-reviewed.
Appropriateness of malaria diagnosis and treatment for fever episodes according to patient history and anti-malarial blood measurement: a cross-sectional survey from Tanzania.
Gallay J., Mosha D., Lutahakana E., Mazuguni F., Zuakulu M., Decosterd L.A., Genton B., Pothin E., 2018/05/21. Malaria journal, 17 (1) p. 209. Peer-reviewed.
 
Quantification of the next-generation oral anti-tumor drugs dabrafenib, trametinib, vemurafenib, cobimetinib, pazopanib, regorafenib and two metabolites in human plasma by liquid chromatography-tandem mass spectrometry.
Cardoso E., Mercier T., Wagner A.D., Homicsko K., Michielin O., Ellefsen-Lavoie K., Cagnon L., Diezi M., Buclin T., Widmer N. et al., 2018/04/15. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1083 pp. 124-136. Peer-reviewed.
 
Cellular effects of AP102, a somatostatin analog with balanced affinities for the hSSTR2 and hSSTR5 receptors.
Streuli J., Harris A.G., Cottiny C., Allagnat F., Daly A.F., Grouzmann E., Abid K., 2018/04. Neuropeptides, 68 pp. 84-89. Peer-reviewed.
 
Infant Exposure to Methylphenidate and Duloxetine During Lactation.
Collin-Lévesque L., El-Ghaddaf Y., Genest M., Jutras M., Leclair G., Weisskopf E., Panchaud A., Ferreira E., 2018/04. Breastfeeding medicine, 13 (3) pp. 221-225. Peer-reviewed.
 
Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services.
Panchaud A., Rousson V., Vial T., Bernard N., Baud D., Amar E., De Santis M., Pistelli A., Dautriche A., Beau-Salinas F. et al., 2018/03. British journal of clinical pharmacology, 84 (3) pp. 568-578. Peer-reviewed.
N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis.
Conus P., Seidman L.J., Fournier M., Xin L., Cleusix M., Baumann P.S., Ferrari C., Cousins A., Alameda L., Gholam-Rezaee M. et al., 2018/02/15. Schizophrenia bulletin, 44 (2) pp. 317-327. Peer-reviewed.
<i>In vitro</i> study of new combinations for local antibiotic therapy with calcium sulphate - Near constant release of ceftriaxone offers new treatment options.
Wahl P., Rönn K., Bohner M., Decosterd L.A., Meier C., Schläppi M., Festa S., Gautier E., 2018. Journal of bone and joint infection, 3 (4) pp. 212-221. Peer-reviewed.
 
Arrêt cardiaque suite à l’administration accidentelle d’amphotéricine B sous forme désoxycholate
Cuda Loredana, Mury Caroline, Pagani Jean-Luc, Revelly Jean-Pierre, Livio Françoise, Aubert John-David, Schaller Marie-Denise, Voirol Pierre, Eggimann Philippe, Que Yok-Ai, 2018. Forum Medical Suisse, 18 (50) pp. 1067-1071.
Is Penicillin Plus Gentamicin Synergistic Against Sessile Group B Streptococcal Isolates? An <i>in Vivo</i> Study With an Experimental Model of Foreign-Body Infection.
Ruppen C., Mercier T., Grandgirard D., Leib S.L., El Haj C., Murillo O., Decosterd L., Sendi P., 2018. Frontiers in microbiology, 9 p. 919. Peer-reviewed.
 
Methods for Personalised Delivery Rate Computation for Propofol IV Administered Anesthetic
Simalatsar Alena, Guidi Monia, Roduit Pierre, Buclin Thierry, 2018. dans Automated Reasoning for System Biology and Medicine, Springer International Publishing.
 
Predictors of residual antimalarial drugs in the blood in community surveys in Tanzania.
Gallay J., Pothin E., Mosha D., Lutahakana E., Mazuguni F., Zuakulu M., Decosterd L.A., Genton B., 2018. PloS one, 13 (9) pp. e0202745. Peer-reviewed.
 
Prescribing issues in the Swiss HIV infected ageing population
Livio F., Rrustemi F., Moffa G., Elzi L., Stader F., Braun D., Calmy A., Hachfeld A., Cavassini M., Tarr P. et al., 2018., 18th International Society of Pharmacovigilance (ISoP) Annual Meeting, Geneva pp. 1252-1253 dans Drug Safety.
Self-reported perinatal depressive symptoms and postnatal symptom severity after treatment with antidepressants in pregnancy: a cross-sectional study across 12 European countries using the Edinburgh Postnatal Depression Scale.
Lupattelli A., Twigg M.J., Zagorodnikova K., Moretti M.E., Drozd M., Panchaud A., Rieutord A., Juraski R.G., Odalovic M., Kennedy D. et al., 2018. Clinical epidemiology, 10 pp. 655-669. Peer-reviewed.
 
Self-reported perinatal depressive symptoms and postnatal symptom severity after treatment with antidepressants in pregnancy: a cross-sectional study in 12 European countries using the Edinburgh Postnatal Depression Scale" has been accepted for publication in "Clinical Epidemiology
Lupattelli A., Twigg M.J., Zagorodnikova K., Moretti M.E., Drozd M., Panchaud A., Rieutord R., Gjergja Juraski R., Odalovic M., Kennedy D. et al., 2018. Clinical Epidemiology pp. xx. Peer-reviewed.
Tamoxifen prolongs survival and alleviates symptoms in mice with fatal X-linked myotubular myopathy.
Gayi E., Neff L.A., Massana Muñoz X., Ismail H.M., Sierra M., Mercier T., Décosterd L.A., Laporte J., Cowling B.S., Dorchies O.M. et al., 2018. Nature Communications, 9 (1) p. 4848. Peer-reviewed.
 
Trabecular bone score (TBS) is associated with sub-clinical vertebral fractures in HIV-infected patients.
Ciullini L., Pennica A., Argento G., Novarini D., Teti E., Pugliese G., Aceti A., Conti F.G., 2018/01. Journal of bone and mineral metabolism, 36 (1) pp. 111-118. Peer-reviewed.
 
Simultaneous determination of selective serotonin reuptake inhibitors and their main metabolites in human breast milk by liquid chromatography-electrospray mass spectrometry.
Weisskopf E., Panchaud A., Nguyen K.A., Grosjean D., Hascoët J.M., Csajka C., Eap C.B., Ansermot N., collaborators of the SSRI-Breast Milk study, 2017/07/01. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1057 pp. 101-109. Peer-reviewed.
 
Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals.
Aouri M., Barcelo C., Guidi M., Rotger M., Cavassini M., Hizrel C., Buclin T., Decosterd L.A., Csajka C., Swiss HIV Cohort Study, 2017/04. Antimicrobial agents and chemotherapy, 61 (1) p. 10. Peer-reviewed.
 
Adverse drug reactions as a cause of admission to intensive care unit: a 4-months prospective cohort study
Berthaut V., Renard D., Schaller M.D., Manzon C., Voirol P., Buclin T., Livio F., 2017., 17th International Society of Pharmacovigilance (ISoP) Annual Meeting, Liverpool p. 944 dans Drug Safety.
 
Direct oral anticoagulants: are they safer than vitamin K antagonists?
Baumberger M., Hugli O., Buclin T., Livio F., 2017., 17th International Society of Pharmacovigilance (ISoP) Annual Meeting, Liverpool pp. 943-944 dans Drug Safety.
 
The levels of vancomycin in the blood and the wound after the local treatment of bone and soft-tissue infection with antibiotic-loaded calcium sulphate as carrier material.
Wahl P., Guidi M., Benninger E., Rönn K., Gautier E., Buclin T., Magnin J.L., Livio F., 2017. The Bone & Joint Journal, 99-B (11) pp. 1537-1544. Peer-reviewed.
 
Use of Dipeptidyl-Peptidase IV Inhibitors and Bullous Pemphigoid.
Schaffer C., Buclin T., Jornayvaz F.R., Cazzaniga S., Borradori L., Gilliet M., Feldmeyer L., 2017. Dermatology, 233 (5) pp. 401-403. Peer-reviewed.
Population Genetic-Based Pharmacokinetic Modeling of Methadone and its Relationship with the QTc Interval in Opioid-Dependent Patients.
Csajka C., Crettol S., Guidi M., Eap C.B., 2016/12. Clinical pharmacokinetics, 55 (12) pp. 1521-1533. Peer-reviewed.
Sélection de cas issus des centres régionaux de pharmacovigilance
Weiler Stefan, Taegtmeyer Anne B., Müller Sabine, Rollason Victoria, Livio Françoise, Ceschi Alessandro, Kullak-Ublick Gerd A., 2016/09/14. Forum Médical Suisse pp. 757-763.
 
Cascaded PID controller for anaesthesia delivery.
Simalatsar A., Guidi M., Buclin T., 2016/08. Conference proceedings, 2016 pp. 533-536. Peer-reviewed.
 
Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals.
Barceló C., Gaspar F., Aouri M., Panchaud A., Rotger M., Guidi M., Cavassini M., Buclin T., Decosterd L.A., Csajka C. et al., 2016/07. The Journal of antimicrobial chemotherapy, 71 (7) pp. 1933-1942. Peer-reviewed.
 
Pregnancy outcome following maternal exposure to pregabalin may call for concern.
Winterfeld U., Merlob P., Baud D., Rousson V., Panchaud A., Rothuizen L.E., Bernard N., Vial T., Yates L.M., Pistelli A. et al., 2016/06/14. Neurology, 86 (24) pp. 2251-2257. Peer-reviewed.
 
Pharmacovigilance [Pharmacovigilance update]
Dao K., Chtioui H., Rothuizen L.E., Diezi L., Prod'hom S., Winterfeld U., Buclin T., Livio F., 2016/01/13. Revue medicale suisse, 12 (500) pp. 75-79.
 
Cas clinique n°5 - fibrillation auriculaire.
Guignard B., Beney Johnny, Panchaud Alice, Csajka Chantal, Meyer Philippe, 2016. pharmaJournal 07 pp. 5-9.
 
Dispelling the "nice or naughty myth" with ecological fallacy.
Hoarau G., Panchaud A., Spodenkiewicz M., Baud D., Gérardin P., 2016. BMJ online p. 1.
Gentamicin Exposure and Sensorineural Hearing Loss in Preterm Infants.
Fuchs A., Zimmermann L., Bickle Graz M., Cherpillod J., Tolsa J.F., Buclin T., Giannoni E., 2016. PloS one, 11 (7) pp. e0158806. Peer-reviewed.
 
Des doutes insuffisants pour changer nos pratiques
Winterfeld Ursula, Baud David, Panchaud Alice, Rothuizen Laura, Livio Françoise, Stoller Rudolf, Buclin Thierry, 2015/10. Bulletin des médecins suisses, 96 (41) pp. 1494-1495.
 
Vitamin D time profile based on the contribution of non-genetic and genetic factors in HIV-infected individuals of European ancestry.
Guidi M., Foletti G., McLaren P., Cavassini M., Rauch A., Tarr P.E., Lamy O., Panchaud A., Telenti A., Csajka C. et al., 2015/07. Antiviral Therapy, 20 (3) pp. 261-269. Peer-reviewed.
 
Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study.
Winterfeld U., Klinger G., Panchaud A., Stephens S., Arnon J., Malm H., Te Winkel B., Clementi M., Pistelli A., Maňáková E. et al., 2015/06. Journal of Clinical Psychopharmacology, 35 (3) pp. 250-259. Peer-reviewed.
 
Cas clinique n°4 - prescription inappropriée chez le patient âgé: entre trop et trop peu de médicaments.
Csajka Chantal, Panchaud Alice, Guignard Bertrand, Beney Johnny, Spinewine Anne, 2015. pharmaJournal 7 pp. 5-7.
 
Erlotinib: another candidate for the therapeutic drug monitoring of targeted therapy of cancer? A pharmacokinetic and pharmacodynamic systematic review of literature.
Petit-Jean E., Buclin T., Guidi M., Quoix E., Gourieux B., Decosterd L.A., Gairard-Dory A.C., Ubeaud-Séquier G., Widmer N., 2015. Therapeutic Drug Monitoring, 37 (1) pp. 2-21. Peer-reviewed.
Genetics-Based Population Pharmacokinetics and Pharmacodynamics of Risperidone in a Psychiatric Cohort.
Vandenberghe F., Guidi M., Choong E., von Gunten A., Conus P., Csajka C., Eap C.B., 2015. Clinical Pharmacokinetics, 54 (12) pp. 1259-1272. Peer-reviewed.
 
Interactions between bupropion and 3,4-methylenedioxymethamphetamine in healthy subjects.
Schmid Y., Rickli A., Schaffner A., Duthaler U., Grouzmann E., Hysek C.M., Liechti M.E., 2015. Journal of Pharmacology and Experimental Therapeutics, 353 (1) pp. 102-111.
 
Pharmacovigilance [Pharmacovigilance update].
Fogarasi Szabo N., Diezi L., Delenclos L., Renard D., Chtioui H., Rothuizen L.E., Buclin T., Livio F., 2015/01. Revue Médicale Suisse, 11 (456-457) pp. 124-128.
 
Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study.
Weber-Schoendorfer C., Oppermann M., Wacker E., Bernard N., network of French pharmacovigilance centres, Beghin D., Beghin D., Cuppers-Maarschalkerweerd B., Richardson J.L., Rothuizen L.E. et al., 2015. British Journal of Clinical Pharmacology, 80 (4) pp. 727-739. Peer-reviewed.
Spectrum of digoxin-induced ocular toxicity: a case report and literature review.
Renard D., Rubli E., Voide N., Borruat F.X., Rothuizen L.E., 2015. Bmc Research Notes, 8 (1) p. 368. Peer-reviewed.
 
Population pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Tanzania.
Mosha D., Guidi M., Mwingira F., Abdulla S., Mercier T., Decosterd L.A., Csajka C., Genton B., 2014/08. Antimicrobial Agents and Chemotherapy, 58 (8) pp. 4583-4592. Peer-reviewed.
 
Antiepileptika bei Frauen im gebärfähigen Alter und in der Schwangerschaft : Vergleich der Fachinformationen in Deutschland und der Schweiz mit dem aktuellen Wissensstand [Antiepileptics in women of childbearing age and during pregnancy : Comparison of specialized information with the current state of knowledge in Germany and Switzerland].
Winterfeld U., Gotta V., Rothuizen L.E., Panchaud A., Rossetti A.O., Buclin T., 2014. Der Nervenarzt, 85 (6) pp. 738-746. Peer-reviewed.
 
High-throughput hydrophilic interaction chromatography coupled to tandem mass spectrometry for the optimized quantification of the anti-Gram-negatives antibiotic colistin A/B and its pro-drug colistimethate.
Mercier T., Tissot F., Gardiol C., Corti N., Wehrli S., Guidi M., Csajka C., Buclin T., Couet W., Marchetti O. et al., 2014. Journal of Chromatography. A, 1369 pp. 52-63. Peer-reviewed.
 
Médicaments et grossesse : modifications pharmacocinétiques et place du suivi thérapeutique pharmacologique [Pharmacokinetic Alterations in Pregnancy and Use of Therapeutic Drug Monitoring].
Panchaud A., Weisskopf E., Winterfeld U., Baud D., Guidi M., Eap C.B., Csajka C., Widmer N., 2014. Therapie, 69 (3) pp. 223-234. Peer-reviewed.
 
Perampanel: a significant liver enzyme inducer in some patients?
Novy J., Rothuizen L.E., Buclin T., Rossetti A.O., 2014. European Neurology, 72 (3-4) pp. 213-216. Peer-reviewed.
 
Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance.
Noetzli M., Guidi M., Ebbing K., Eyer S., Wilhelm L., Michon A., Thomazic V., Stancu I., Alnawaqil A.M., Bula C. et al., 2014. British Journal of Clinical Pharmacology, 78 (1) pp. 135-144. Peer-reviewed.
Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals.
Arab-Alameddine M., Lubomirov R., Fayet-Mello A., Aouri M., Rotger M., Buclin T., Widmer N., Gatri M., Ledergerber B., Rentsch K. et al., 2014. Journal of Antimicrobial Chemotherapy, 69 (9) pp. 2489-2498. Peer-reviewed.
 
Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates.
Fuchs A., Guidi M., Giannoni E., Werner D., Buclin T., Widmer N., Csajka C., 2014. British Journal of Clinical Pharmacology, 78 (5) pp. 1090-1101. Peer-reviewed.
 
Abus de psychotropes : médicaments et drogues
Yersin Bertrand, Feiner Adam-Scott, Livio Françoise, 2013. pp. 246-256 dans Médecine d'urgence préhospitalière chap. 30, Editions Médecine & Hygiène .
 
Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania.
Staehli Hodel E.M., Csajka C., Ariey F., Guidi M., Kabanywanyi A.M., Duong S., Decosterd L.A., Olliaro P., Beck H.P., Genton B., 2013. Antimicrobial Agents and Chemotherapy, 57 (2) pp. 950-958.
 
Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals.
Lubomirov R., Arab-Alameddine M., Rotger M., Fayet-Mello A., Martinez R., Guidi M., di Iulio J., Cavassini M., Günthard H.F., Furrer H. et al., 2013. Pharmacogenetics and Genomics, 23 (1) pp. 9-18. Peer-reviewed.
 
Population pharmacokinetic study of memantine: effects of clinical and genetic factors.
Noetzli M., Guidi M., Ebbing K., Eyer S., Wilhelm L., Michon A., Thomazic V., Alnawaqil A.M., Maurer S., Zumbach S. et al., 2013. Clinical Pharmacokinetics, 52 (3) pp. 211-223. Peer-reviewed.
Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients.
Staehli Hodel E.M., Guidi M., Zanolari B., Mercier T., Duong S., Kabanywanyi A.M., Ariey F., Buclin T., Beck H.P., Decosterd L.A. et al., 2013. Malaria Journal, 12 p. 235. Peer-reviewed.
 
Prediction of free imatinib concentrations based on total plasma concentrations in patients with gastrointestinal stromal tumours.
Haouala A., Widmer N., Guidi M., Montemurro M., Leyvraz S., Buclin T., Eap C.B., Decosterd L.A., Csajka C., 2013. British Journal of Clinical Pharmacology, 75 (4) pp. 1007-1018. Peer-reviewed.
 
Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
Winterfeld U., Allignol A., Panchaud A., Rothuizen L.E., Merlob P., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M. et al., 2013. BJOG, 120 (4) pp. 463-471. Peer-reviewed.
 
Relationship of CYP2D6, CYP3A, POR, and ABCB1 Genotypes With Galantamine Plasma Concentrations.
Noetzli M., Guidi M., Ebbing K., Eyer S., Zumbach S., Giannakopoulos P., von Gunten A., Csajka C., Eap C.B., 2013. Therapeutic Drug Monitoring, 35 (2) pp. 270-275. Peer-reviewed.
 
Dosage optimization of treatments using population pharmacokinetic modeling and simulation.
Guidi M., Arab-Alameddine M., Rotger M., Aouri M., Telenti A., Decosterd L.A., Buclin T., Csajka C., Swiss HIV Cohort Study, 2012. Chimia, 66 (5) pp. 291-295. Peer-reviewed.
 
Pharmacie clinique en Suisse romande
Guignard B, Csajka Chantal, Beney J, Bugnon Olivier, Bonnabry Pascal, 2012. pp. 1277-1290 dans Calop J, Limat S, Fernandez C, Aulagner G (eds.) Pharmacie clinique et thérapeutique chap. 65, Elsevier Masson.
 
Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study.
Panchaud A., Csajka C., Merlob P., Schaefer C., Berlin M., De Santis M., Vial T., Ieri A., Malm H., Eleftheriou G. et al., 2012. Journal of Clinical Pharmacology, 52 (12) pp. 1844-1851. Peer-reviewed.
Utilisation des laxatifs à l'Hôpital
Dao Kim, Renard Delphine, Livio Françoise, Buclin Thierry, De Giorgi I, 2012. GSASA Journal 26 pp. 27-31.
Additifs alimentaires et troubles de l’attention/hyperactivité chez l’enfant
Diezi Manuel, Buclin Thierry, Diezi Jacques, 2011. Paediatrica, 22 (5) pp. 12-15.
 
Cholelithiasis: obesity complication or orlistat adverse reaction?
Melnikova Martinez-Esteve A., Genin B., Livio F., Produit S., Cheseaux J.J., Llor J., Marcoz J., Tabin R., 2011., Congrès commun des Sociétés suisses de Pédiatrie, Chirurgie pédiatrique, Psychiatrie et Psychothérapie d'enfants et d'adolescents, Montreux pp. 31S dans Swiss Medical Weekly.
 
Traitements de fer: preuves de l'efficacité et bonne pratique clinique [Iron therapy: proof of efficacy and good clinical practice].
Renard D., Favrat B., Livio F., Buclin T., 2011. Revue Médicale Suisse, 7 (292) pp. 923-927.
 
Pharmacovigilance update [Pharmacovigilance update]
Livio F., Ivanyuk A., Biollaz J., Rothuizen L., Buclin T., 2010. Revue Médicale Suisse, 6 (232) pp. 128-131.
 
Spectroscopy of protonated peptides assisted by infrared multiple photon excitation.
Guidi M., Lorenz U.J., Papadopoulos G., Boyarkin O.V., Rizzo T.R., 2009/02/05. The journal of physical chemistry. A, 113 (5) pp. 797-799. Peer-reviewed.
 
Formation et recherche en pharmacie hospitalière et communautaire – état des lieux et perspectives en Suisse romande
Pannatier André, Bugnon Olivier, Csajka Chantal, Bonnabry Pascal, 2009. Pharmactuel, 42 (Suppl. 1) pp. 53-61. Peer-reviewed.
 
Pharmacodynamic interaction between SSR180575 and enalapril on the blood pressure response to angiotensin-I challenges in healthy normotensive male volunteers
Livio F., Buclin T., Nussberger J., Appenzeller M., Gaud C., Duluc M.E., Pinquier J.L., Biollaz J., 2009., Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Edinburgh p. 83 dans Basic and Clinical Pharmacology and Toxicology.
 
Estimation de la fonction rénale par l'equation MDRD: intérêt et limites pour l'adaptation des doses de médicaments [Renal function estimation by MDRD equation: interest and limitations for drug dosing].
Livio F., Biollaz J., Burnier M., 2008. Revue Médicale Suisse, 4 (181) pp. 2596-2600.
 
Médicaments et allaitement: quelques éléments à considérer avant de les juger incompatibles [Drugs and breastfeeding: some facts to consider before deciding they are incompatible]
Panchaud A., Fischer C., Rothuizen L., Buclin T., 2008. Revue Médicale suisse, 4 (146) pp. 540-545.
 
Pharmacovigilance [Pharmacovigilance update]
Livio F., Buclin T., Biollaz J., 2008. Revue Médicale Suisse, 4 (140) pp. 150-154.
 
Conformation-specific infrared and ultraviolet spectroscopy of tyrosine-based protonated dipeptides.
Stearns J.A., Guidi M., Boyarkin O.V., Rizzo T.R., 2007/10/21. The Journal of chemical physics, 127 (15) p. 154322. Peer-reviewed.
 
Conformation-specific spectroscopy and photodissociation of cold, protonated tyrosine and phenylalanine.
Stearns J.A., Mercier S., Seaiby C., Guidi M., Boyarkin O.V., Rizzo T.R., 2007/09/26. Journal of the American Chemical Society, 129 (38) pp. 11814-11820. Peer-reviewed.
 
Some properties of lysozyme--lithium perfluorononanoate complexes.
Ciurleo A., Cinelli S., Guidi M., Bonincontro A., Onori G., Mesa C.L., 2007/02. Biomacromolecules, 8 (2) pp. 399-405. Peer-reviewed.
 
Effect of dronedarone on renal function in healthy subjects.
Tschuppert Y., Buclin T., Rothuizen L.E., Decosterd L.A., Galleyrand J., Gaud C., Biollaz J., 2007. British Journal of Clinical Pharmacology, 64 (6) pp. 785-791. Peer-reviewed.
 
Generiques et article 38a OPAS: quel impact? [Generic drugs and legal incentives: which impact?]
Livio F., Buclin T., Pannatier A., Biollaz J., 2006/04. Revue Médicale Suisse, 2 (61) pp. 966-9.
 
Ne pas negliger le risque de surtraitement: l'exemple des antiepiteptiques. [Risk of overtreatment: not to be neglected. The example of antiepileptic drugs]
Rothuizen L. E., Buclin T., Reichhart M., Biollaz J., 2006/04. Revue Médicale Suisse, 2 (61) pp. 976-80.
 
Effets du cannabis oral et du dronabinol sur la capacité à conduire [Effects of oral cannabis and dronabinol on driving capacity]
Giroud C., Augsburger M., Favrat B., Menetrey A., Pin M.A., Rothuizen L.E., Appenzeller M., Buclin T., Mathieu S., Castella V. et al., 2006. Annales Pharmaceutiques Françaises, 64 (3) pp. 161-172.
 
Pharmacovigitance--pharmaco-epidemiologie. [Trends in drug therapy]
Livio F., Buclin T., Biollaz J., 2006/01. Revue Médicale Suisse, 2 (48) pp. 155-9.
 
Anaphylactic reaction and unrelated, subsequent, known side effects during therapy with thiethylperazine.
Rossetti G., Livio F., Roulet E., Hofer M.F., 2005/08. Pediatric allergy and immunology, 16 (5) pp. 453-455. Peer-reviewed.
Two cases of "cannabis acute psychosis" following the administration of oral cannabis.
Favrat B., Ménétrey A., Augsburger M., Rothuizen L.E., Appenzeller M., Buclin T., Pin M., Mangin P., Giroud C., 2005/04/01. BMC psychiatry, 5 p. 17. Peer-reviewed.
Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.
Ménétrey A., Augsburger M., Favrat B., Pin M.A., Rothuizen L.E., Appenzeller M., Buclin T., Mangin P., Giroud C., 2005. Journal of Analytical Toxicology, 29 (5) pp. 327-338. Peer-reviewed.
 
Douleurs abdominales et ictere cholestatique recidivant. [Abdominal pain and recurrent cholestatic jaundice]
Livio Ndiaye F., Wiesel P. H., Goy J. J., Genton A., 2004/06. Schweizerische Rundschau fur Medizin Praxis, 93 (24) pp. 1051-4.
 
Acute rhinosinusitis : a pharmacoeconomic review of antibacterial use
Wasserfallen J. B., Livio F., Zanetti G., 2004. Pharmacoeconomics, 22 (13) pp. 829-37. Peer-reviewed.
A pregnant woman with de novo polyuria-polydipsia and elevated liver enzymes.
Barbey F., Bonny O., Rothuizen L., Gomez F., Burnier M., 2003. Nephrology, Dialysis, Transplantation, 18 (10) pp. 2193-2196.
 
Evaluation of online telemonitoring of drug adherence: a pilot randomized, controlled study in patients with epilepsy.
Schneider M.P, Despland P.A, Buclin Th., Burnier M, 2003. The Journal on Information Technology in Healthcare, 1(6) pp. 419-435.
 
Hyponatrémie: une histoire en deux temps... [Hyponatremia: an unusual case report]
Berwert L., Kaeser P., Livio F., Vollenweider P., Waeber G., 2003. Praxis, 92 (41) pp. 1727-32.
 
Transplantation et goutte .
Livio Ndiaye F, Dudler J, 2003. Médecine et Hygiène pp. 2099-2104.
 
Prévention et traitement de l'insuffisance rénale aiguë : rôle des traitements diurétiques
Livio F., 2002. Médecine et Hygiène, 60 (2387) pp. 727-730.
 
Rate, type, and cost of adverse drug reactions in emergency department admissions.
Wasserfallen J., Livio F., Buclin T., Tillet L., Yersin B., Biollaz J., 2001. European Journal of Internal Medicine, 12 (5) pp. 442-447.
 
Wegener's granulomatosis: description of a case where cutaneous involvement was correlated with elevation of the c-ANCA titer
Mock M., Cerottini J. P., Derighetti M., Buxtorf K., Livio F., Panizzon R. G., 2001. Dermatology, 202 (4) pp. 347-9.
 
Intoxication au lithium
Livio F., Wauters J.P., 2000. Médecine et Hygiène, 58 (2289) pp. 426-430.
 
Les intoxications médicamenteuses volontaires
Buclin T., Livio F., Yersin B., Biollaz J., 2000. pp. 113-119 dans L'abus de médicaments en Suisse chap. 11, SFA-ISPA PRESS, Lausanne.
 
Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers.
Rothuizen L.E., Buclin T., Spertini F., Trinchard I., Munafo A., Buchwalder P.A., Ythier A., Biollaz J., 1999. Journal of Neuroimmunology, 99 (1) pp. 131-141.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University